Ntusi et al. reported reduced inflammatory markers and myocardial inflammation after anti-TNF-alpha treatment in a cohort with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis [41]. Here, TNF is linked to ankylosing spondylitis.